4//SEC Filing
COHEN RON 4
Accession 0001209191-18-061102
CIK 0001008848other
Filed
Dec 5, 7:00 PM ET
Accepted
Dec 6, 8:00 AM ET
Size
6.0 KB
Accession
0001209191-18-061102
Insider Transaction Report
Form 4
COHEN RON
President and CEO
Transactions
- Sale
Common Stock
2018-12-03$20.60/sh−3,620$74,554→ 487,554 total
Holdings
- 120,000(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Sales pursuant to a 10b5-1 plan. These sales are primarily intended to cover the tax liability resulting from restricted stock vesting.
- [F2]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $20.5200 to $20.6400 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F3]The shares are held in grantor retained annuity trust, which was established by the reporting person and of which he is the sole trustee.
Documents
Issuer
ACORDA THERAPEUTICS INC
CIK 0001008848
Entity typeother
Related Parties
1- filerCIK 0001272354
Filing Metadata
- Form type
- 4
- Filed
- Dec 5, 7:00 PM ET
- Accepted
- Dec 6, 8:00 AM ET
- Size
- 6.0 KB